Managers / Q2 2020 · view latest →
KNOTT DAVID M
CIK 0000808722
Summary
Knott David M reported $183M in U.S.-listed holdings across 127 positions for Q2 2020.
Its largest position, LGND, represents 16.0% of the portfolio.
Compared with Q1 2020, the fund opened 11 new positions and exited 40.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.6% · $153M
- Other · 6.7% · $12M
- Ltd Part · 5.0% · $9M
- MLP · 4.2% · $8M
- REIT · 0.5% · $945,000
- Other · 0.1% · $113,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| FTAIEURFortress Trans & Infrastructure Inv. LLC | NEW | +700.0K | 700.0K | +$9M | $9M |
| FSKFS KKR Capital Corp. | NEW | +395.2K | 395.2K | +$6M | $6M |
| Kennedy-Wilson Holdings, Inc. | NEW | +210.0K | 210.0K | +$3M | $3M |
| TGTXTG Therapeutics Inc. | NEW | +12.0K | 12.0K | +$234,000 | $234,000 |
| CYTKCytokinetics Incorporated | NEW | +8.9K | 8.9K | +$210,000 | $210,000 |
| RLMDRelmada Therapeutics, Inc. | NEW | +3.0K | 3.0K | +$134,000 | $134,000 |
| TARAProtara Therapeutics, Inc. | NEW | +3.8K | 3.8K | +$112,000 | $112,000 |
| CUZCousins Properties | NEW | +3.4K | 3.4K | +$100,000 | $100,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2021 | $275M | 197 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $281M | 195 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $234M | 166 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $221M | 145 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $170M | 135 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $183M | 127 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $158M | 156 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $247M | 152 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $238M | 157 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $237M | 148 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $251M | 143 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $213M | 133 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DORSET MANAGEMENT CORP028-10281
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.